Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a Naturally Occurring Dual FFAR Agonist on Incretins, Insulin Secretion, Lipids and Inflammation in Obesity and Type 2 Diabetes

NCT03062592 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT03062592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a Naturally Occurring Dual FFAR Agonist on Incretins, Insulin Secretion, Lipids and Inflammation in Obesity and Type 2 Diabetes
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
April 30, 2016
Enrollment
8 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type2 diabetes mellitus